0.0050
0.0000
(0.00%)
At close: January 28 at 11:53:04 AM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-5,385.1280
-10,239.8880
-30,166.3860
-30,007.0760
-35,538.7060
Investing Cash Flow
-130.0690
7,660.6870
-1,316.9490
1,841.4230
-1,400.9120
Financing Cash Flow
-287.6050
2,657.5760
21,142.5190
24,063.6430
51,261.3070
End Cash Position
3,619.3940
11,253.6320
11,175.2570
21,516.0730
25,618.0830
Capital Expenditure
-631.4080
-1,199.0590
-1,696.9680
-502.8730
-1,540.1240
Issuance of Capital Stock
--
--
--
15,582.3700
25,000.0000
Issuance of Debt
--
14,773.5420
38,314.8580
20,991.1280
32,435.7720
Repayment of Debt
-173.2800
-10,833.3890
-15,205.5010
-9,893.4620
-3,173.0160
Free Cash Flow
-6,016.5360
-11,438.9470
-31,863.3540
-30,509.9490
-37,078.8300
12/31/2020 - 1/2/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
KHRNF Khiron Life Sciences Corp.
0.0001
0.00%
AX9.SG Akebia Therapeutics Inc
2.1800
+0.93%
6CQ.BE Cresco Labs Inc
0.8460
-0.29%
AX9.F Akebia Therapeutics, Inc.
2.1560
-2.53%
BON.SG Boiron SA
25.70
+0.98%
RAPH Raphael Pharmaceutical Inc.
1.0000
0.00%
NECLIFE.BO Nectar Lifesciences Limited
34.82
-4.99%
EGRX Eagle Pharmaceuticals, Inc.
0.8000
-11.11%
SHE.MI Shedir Pharma Group S.p.A.
4.8800
0.00%
1513.HK LIVZON PHARMA
26.350
-0.38%